Generics Come Out on Top Over Canadian Brand Drugs

MARCH 01, 2004

While Americans are hopping onto buses to buy drugs from Canada in the hopes of saving money, new research by the FDA sheds some light on this expectation. The report claims that Americans could pay significantly more for drugs in Canada than if they bought generic versions here at home.

Mark McClellan, MD, PhD, FDA commissioner, believes that, for many people, buying US generics is a risk-free alternative to imports and could reduce their pharmacy bill.

To back his argument, the FDA evaluated price data culled by IMS Health. The data included 7 drugs whose generic versions are top-selling treatments for chronic disease: the antidepressant fluoxetine (Prozac); blood pressure medicines metoprolol (Lopressor), lisinopril (Prinivil), and enalapril (Vasotec); alprazolam (Zanax) for anxiety; clonazepam (Klonopin) for seizures; and metformin (Glucophage) for diabetes.

For the study, the agency used the price that pharmacies paid for each drug in 2002, the latest full year for which prices from both countries were available from IMS. The study measured average price per milligram. When comparing both brand name and generic versions in Canada, the US generics were far less expensive for all but Glucophage, the study showed.


In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.



Conference Coverage
News from the year's biggest meetings

Pharmacist Education
Clinical features with downloadable PDFs


Personalize the information you receive by selecting targeted content and special offers.